Alkermes plc (ALKS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Alkermes plc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
ALKS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ALKS as an investment opportunity.
- ALKS has a higher upside potential (average analyst target price relative to current price) than 10.61% of Pharmaceutical Products stocks.
- The number of analysts covering the stock of ALKS is greater than 86.67% of Pharmaceutical Products stocks.
- ALKS has a greater average analyst price target than 16.76% of stocks in the large market cap category.
- Alkermes plc's variance in analysts' estimates is less than 19.02% of all US stocks.
- The percent of analysts bearish on the stock of ALKS is less than just about 100% of all US stocks.
- ALKS has a greater percentage of analysts bullish on the stock than nearly none of all US stocks.
- ALKS has a lower change in bullishness amongst analysts than just about 100% of all US stocks.
Make investment decisions regarding ALKS using the data that counts. Try POWR Ratings for free.